Werewolf Therapeutics (HOWL) Market Cap

Price: $0.8907
Market Cap: $39.93M
Avg Volume: 257.05K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.484
52W Range: $0.595-6.89
Website: Werewolf Therapeutics

Market Cap Overview

Market Cap

$39.93M

Share Price

$0.8907

Shares Outstanding

44.83M


What is Werewolf Therapeutics's Market Cap?

Werewolf Therapeutics's current Market Cap as of today is $39.93M.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Werewolf Therapeutics, the market cap is calculated as $0.8907 x 44.83M shares = $39.93M.

As a Micro Cap company, Werewolf Therapeutics is a very small company that may be in its early stages.

Werewolf Therapeutics Historical Market Cap

$600.00M$600.00M$500.00M$500.00M$400.00M$400.00M$300.00M$300.00M$200.00M$200.00M$100.00M$100.00M$0.00$0.00Market CapJul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Werewolf Therapeutics Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Werewolf Therapeutics, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$500.00M$500.00M$400.00M$400.00M$300.00M$300.00M$200.00M$200.00M$100.00M$100.00M$0.00$0.00-$100.00M-$100.00MValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Werewolf Therapeutics's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:

  • Market Cap: $39.93M
  • Total Debt: $37.09M
  • Cash and Equivalents: $111.00M
  • Enterprise Value: $-8.08M

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A lower enterprise value indicates a strong net cash position.

Werewolf Therapeutics Annual Market Cap History

Year Market Cap Change
2025 $39.93M -37.74%
2024 $64.13M -53.39%
2023 $137.60M 132.54%
2022 $59.17M -81.81%
2021 $325.30M -29.51%
2020 $461.50M 0.00%
2019 $461.50M N/A

Frequently Asked Questions

Werewolf Therapeutics's current market capitalization is $39.93M. This makes it a Micro Cap company, calculated by multiplying its current stock price of $0.8907 by 44.83M outstanding shares.

Werewolf Therapeutics's enterprise value is $-8.08M. This is calculated by adding total debt ($37.09M) to market cap and subtracting cash and equivalents ($111.00M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Werewolf Therapeutics has 44.83M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Werewolf Therapeutics is classified as a Micro Cap company. Micro-cap companies are the smallest publicly traded companies with market caps below $300 million.

Werewolf Therapeutics's market cap is calculated by multiplying its current stock price ($0.8907) by its total number of outstanding shares (44.83M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for HOWL.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio